Evaluation of the Safety of Poziotinib in Combination With TDM1 in Women with Advanced or MetastaticHER2+ Breast Cancer

Project: Research project

Project Details

Description

Evaluation of the Safety of Poziotinib in Combination With TDM1 in Women with Advanced or Metastatic HER2+ Breast Cancer
StatusFinished
Effective start/end date10/17/177/1/19

Funding

  • Spectrum Pharmaceuticals, Inc.